@DeepJagMD profile picture
Deepa Jagadeesh, MD @DeepJagMD
Joined July 2016
  • Tweets 380
  • Following 185
  • Followers 343
81 Photos and videos
Crossing finish line ⁦@bikeVeloSano⁩ ⁦@ClevelandClinic⁩
5
559
Strong finish ⁦@hamiltkyb⁩⁦@bikeVeloSano⁩ ⁦@ClevelandClinic⁩ ⁦@CleClinicMD⁩
2
18
1,579
Finishing strong ⁦@TiffanyOnger⁩ ⁦@bikeVeloSano⁩ ⁦@ClevelandClinic⁩ ⁦@CleClinicMD⁩
1
276
25 mile ⁦@bikeVeloSano⁩ ⁦@ClevelandClinic⁩ ⁦@CleClinicMD⁩
1
224
25 mile ⁦@bikeVeloSano⁩ getting ready! ⁦@ClevelandClinic⁩ ⁦@CleClinicMD⁩ #CleClinCancer
3
230
Why I ride. ⁦@bikeVeloSano⁩ ⁦@ClevelandClinic⁩ ⁦@CleClinicMD⁩ #cancerresearch
1
4
315
Waiting in line! ⁦@bikeVeloSano⁩ ⁦@ClevelandClinic⁩ ⁦@CleClinicMD⁩ #cleclincancer#cancerresearch
1
164
Volunteers rocking! ⁦⁦@bikeVeloSano⁩ #CCFBMT ⁦@CleClinicMD⁩ ⁦@ClevelandClinic⁩
15
418
Deepa Jagadeesh, MD retweeted
Brian Hill@BrianHill_MDPhD
9 Jul 2023
Congratulations to @DeepJagMD for representing #CleClinicCancer in the newly-published results of Pirtobrutinib in NEJM. Great to have more access to this important new treatment for our patients with #CLL, #CLLSociety nejm.org/doi/full/10.1056/NE…

Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia | NEJM

Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) have poor outcomes after the failure of covalent Bruton’s tyrosine kinase (BTK) inhibitor treatment, and new the...

nejm.org
1
3
21
2,467
Deepa Jagadeesh, MD retweeted
Pauline Funchain@FunchainMD
15 Jun 2023
Folks it doesn’t get any better than moments like this - the spontaneous teamwork to get this silly picture going was ✨ 📸me, June 2023 🍷none other than Dr. David Adelstein, circa 2011 🐐
4
23
1,387
Deepa Jagadeesh, MD retweeted
Bloodbytes
@DrSwami_Iyer
5 Jun 2023
Just out! Outstanding work from Jessie Xu,DUSP22rearrangement generally positive for CD15, CD8, and less frequently expressed pSTAT3Tyr705 a distinctive immunophenotype but lower OS compared to ALK ALCL: Haematologica haematologica.org/article/vi….
5
9
1,457
Deepa Jagadeesh, MD retweeted
Shilpa Gupta
@shilpaonc
10 Mar 2023
Inspiring speech by @perez_protto @CleClinicMD @theWPSA President 2023 Ask “What can women add to the organization” not the other way around. @TomMihaljevicMD @beridgeway @RitaPappasMD @DeepJagMD @smitha42 @jamecancerdoc @JLGeigerMD
1
1
10
998
Deepa Jagadeesh, MD retweeted
Shilpa Gupta
@shilpaonc
10 Mar 2023
Such an inspiring event @WPSA1 Nnual meeting @CleClinicMD Remarkable to see so many women in leadership! @DeepJagMD @smitha42 @FunchainMD @JLGeigerMD @RitaPappasMD #HeForShe @jamecancerdoc @beridgeway @perez_protto
6
34
1,980
Great event supporting women staff at Cleveland clinic ⁦@ClevelandClinic⁩ ⁦@CleClinicMD⁩ ⁦@RitaPappasMD⁩ ⁦@WPSA1⁩
2
12
776
Deepa Jagadeesh, MD retweeted
Jame Abraham, MD, FACP@jamecancerdoc
14 Feb 2023
Congratulations and thanks to our outstanding colleagues, leadership of Josalyn Meyer ( Director of Nursing) Physician leaders like ⁦@DeepJagMD⁩ - opening of the beautiful, renovated inpatient Lymphoma Myeloma Service ⁦@ClevelandClinic⁩ ⁦@CleClinicMD⁩
1
2
36
2,534
Deepa Jagadeesh, MD retweeted
NBCA
@StopTheClot
10 Feb 2023
Globally only 30% of researchers are women vs 70% of NBCA’s Council of Emerging Researchers in Thrombosis. Bravo to @dangeliniMD & @rushadpatell for helping close the #gendergap! stoptheclot.org/council-of-e… #womenandgirlsinscience #stoptheclot @WomenScienceDay @ClevelandClinic
2
10
23
3,539
Incidence of secondary heme malignancies in CLL. Awesome job Rahul! ⁦@RahulMishraMBBS⁩ ⁦@AgrimaMianMD⁩ ⁦@paolocaimiMD⁩ #CleClinicCanc ⁦@CleClinicMD⁩ #ASH22
6
5
48
Long term follow up of RATHL trial confirmed omitting bleo had no impact on outcomes. Secondary cancers more in ABVD/AVD compared to BEACOPP, which is surprising. @StefanoLuminari #ASH22 @CleClinicMD
5
A-HIPI new prognostic score for advanced stage HL! Great work. ⁦@AngieRodday⁩ @DrAEvens⁩ #ASH22 ⁦@CleClinicMD⁩
1
3
CR to RICE predicts better outcome in early relapse DLBCL ⁦@CaimiPaolo⁩ #ASH22 #CleClinicCan ⁦@CleClinicMD⁩
1
Load more